chr3-38365627-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005108.4(XYLB):āc.398A>Gā(p.Asp133Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,460,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D133N) has been classified as Benign.
Frequency
Consequence
NM_005108.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XYLB | NM_005108.4 | c.398A>G | p.Asp133Gly | missense_variant | 6/19 | ENST00000207870.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XYLB | ENST00000207870.8 | c.398A>G | p.Asp133Gly | missense_variant | 6/19 | 1 | NM_005108.4 | P1 | |
XYLB | ENST00000650590.1 | c.317A>G | p.Asp106Gly | missense_variant | 5/18 | ||||
XYLB | ENST00000649234.1 | c.398A>G | p.Asp133Gly | missense_variant, NMD_transcript_variant | 6/20 | ||||
XYLB | ENST00000424034.5 | c.*61A>G | 3_prime_UTR_variant, NMD_transcript_variant | 4/17 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460724Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726474
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.398A>G (p.D133G) alteration is located in exon 6 (coding exon 6) of the XYLB gene. This alteration results from a A to G substitution at nucleotide position 398, causing the aspartic acid (D) at amino acid position 133 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.